ColonPRO 4.0 (CPRO40S-US)
Overview
The ColonPRO™ 4.0 (CPRO40S-US) is an artificial intelligence-based software component of the GI Genius™ intelligent endoscopy module, developed by Cosmo Artificial Intelligence – AI. It is designed to assist endoscopists in real-time detection of colonic mucosal lesions, such as polyps and adenomas, during standard white-light colonoscopy examinations for screening and surveillance. The system analyzes live video images from any compatible endoscope and provides visual markers (e.g., green boxes) on the display to highlight suspicious areas, thereby enhancing lesion detection rates and supporting clinical decision-making. It is not intended to replace the physician’s judgment.
ColonPRO™ 4.0 features improved detection performance through a retrained neural network and introduces a non-clinical “Procedure Highlights” function for data aggregation, supporting healthcare organizations in optimizing their practices.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Use Cases
- Real-time assistance during colonoscopy procedures
- Enhancing detection of colonic polyps and adenomas
- Improving adenoma detection rates (ADR)
- Supporting screening programs for colorectal cancer
- Facilitating surveillance endoscopic mucosal evaluations
- Data aggregation for practice optimization (via Procedure Highlights)
What Physicians Need to Know
ColonPRO™ 4.0 acts as an ever-vigilant second observer, enhancing polyp detection during colonoscopy without altering your standard procedure or withdrawal time. Utilize the real-time polyp sizing module for accurate measurements to guide post-polypectomy surveillance intervals. Leverage the quality module for automated tracking of key metrics like inspection times and cecum detection to optimize your practice. While the system aids in detection, it is not intended to replace clinical decision-making or characterize lesions in a manner that would replace biopsy sampling.
The GI Genius™ system, powered by NVIDIA Holoscan and IGX Orin, is designed as a cohesive platform to support a variety of future real-time AI applications through a single platform. It is positioned for future electronic health record integration and supports third-party application development.
Details
| Category | Gastroenterology AI |
| Pricing | Unknown |
| Deployment | On-premise, integrated with the GI Genius™ intelligent endoscopy module hardware. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status |
Cleared AI-estimated ColonPRO™ 4.0 (CPRO40S-US) received FDA clearance. The GI Genius™ intelligent endoscopy module, which ColonPRO™ software runs on, received De Novo FDA clearance in 2021 as the first and only commercially available computer-aided detection (CADe) system using AI to identify colorectal polyps. It is a computer-assisted reading tool designed to aid endoscopists in detecting colonic mucosal lesions (such as polyps and adenomas) in real time during standard white-light endoscopy examinations of patients undergoing screening and surveillance endoscopic mucosal evaluations. The device is limited for use with standard white-light endoscopy imaging only and is not intended to replace clinical decision making. ColonPRO™ 4.0 has also been identified as the first FDA-approved computer-aided quality (CAQ) platform for use in colonoscopy. |
| GDPR | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Colorectal Surgery, Gastroenterology |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-07-25 | K241887 510(k) | ColonPRO 4.0 (CPRO40S-US) |
What the Web Says
Medtronic's ColonPRO™ 4.0 (CPRO40S-US) is the latest generation AI-assisted software for colonoscopy, designed to enhance polyp detection and improve procedural quality. It has received CE Mark approval and FDA clearance, and studies indicate it significantly reduces adenoma and polyp miss rates compared to standard colonoscopies. The system also offers real-time polyp size estimation and comprehensive procedural highlights to optimize colonoscopy practice.
Overall: PositiveStrengths
- Significantly decreases the miss rate of colorectal polyps and adenomas.
- Increases adenoma detection rates (ADR) by up to 14.4%.
- Reduces adenoma miss rates by approximately 50%.
- Provides real-time polyp size estimation.
- Offers comprehensive procedural highlights, automating workflow and reducing administrative burden.
- High sensitivity rate (99.7%) and low false positives (less than 1%).
Limitations
- One physician reviewer noted that the economic value of an earlier version of the CAQ program seemed to be zero, as some features like total procedure and withdrawal times are already easily obtainable.
- The same reviewer found the CAQ program's rating of Boston Bowel Preparation Scale (BBPS) scores to be inaccurate, potentially altering recall recommendations in a significant percentage of cases.
- The earlier version of the program did not provide real-time feedback on mucosal exposure, withdrawal speed, or actual inspection time, which were identified as valuable potential features.
- General Medtronic customer service and product reliability (for other products) have received negative feedback on Trustpilot.
Based on reviews from: lww.com, medtronic.com, scilit.com, cnet.com, biopharmawatch.com, massdevice.com, asge.org, medicaldesignandoutsourcing.com, youtube.com, trustpilot.com, surgicalroboticstechnology.com, reddit.com, medicaldesigndevelopment.com, reachmd.com
Last updated: 2026-10-29
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ColonPRO 4.0 (CPRO40S-US)
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for ColonPRO 4.0 (CPRO40S-US).







